Suliqua 100/50

Suliqua 100/50 is a medicine authorised by Swissmedic under authorisation number 66283. The authorisation holder is Sanofi-Aventis (Suisse) SA. The medicinal product code is Biotechnological medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 05 October 2017 and the authorisation is valid without a time limit. ATC code A10AE places the medicine in the group Drugs used in diabetes.

  • Dispensing category B
  • Authorisation number 66283
  • ATC A10AE
  • Biotechnological medicines
Authorisation data
Authorisation number66283
NameSuliqua 100/50
Full nameSuliqua 100/50, solution injectable
Authorisation holderSanofi-Aventis (Suisse) SA
Medicinal product codeBiotechnological medicines
Dispensing categoryB · Prescription only
ATC codeA10AE
First authorisation05 October 2017
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
1Suliqua 100/50, solution injectableB05 October 2017
2Suliqua 100/33, solution injectableB05 October 2017

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
13StückA10AE07.06.B
33StückA10AE07.06.B

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Suliqua 100/50 authorised in Switzerland?

Yes. Suliqua 100/50 is authorised by Swissmedic under authorisation number 66283, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Suliqua 100/50 have?

Suliqua 100/50 is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Suliqua 100/50?

The authorisation holder is Sanofi-Aventis (Suisse) SA. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com